228 related articles for article (PubMed ID: 2774656)
1. Animal models of androgen-dependent disorders of the pilosebaceous apparatus. 1. The androchronogenetic alopecia (AGA) mouse as a model for male-pattern baldness.
Matias JR; Malloy V; Orentreich N
Arch Dermatol Res; 1989; 281(4):247-53. PubMed ID: 2774656
[TBL] [Abstract][Full Text] [Related]
2. The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse.
Park WS; Lee CH; Lee BG; Chang IS
J Dermatol Sci; 2003 Apr; 31(2):91-8. PubMed ID: 12670719
[TBL] [Abstract][Full Text] [Related]
3. The effect of testosterone, cyproterone acetate, and minoxidil on hair loss in the androchronogenetic alopecia mouse.
Matias JR; Orentreich N
Clin Dermatol; 1988; 6(4):169-76. PubMed ID: 3214819
[No Abstract] [Full Text] [Related]
4. Synergistic therapeutic effect of ginsenoside Rg3 modified minoxidil transfersomes (MXD-Rg3@TFs) on androgenic alopecia in C57BL/6 mice.
Liu X; Kong X; Xu L; Su Y; Xu S; Pang X; Wang R; Ma Y; Tian Q; Han L
Int J Pharm; 2024 Apr; 654():123963. PubMed ID: 38430952
[TBL] [Abstract][Full Text] [Related]
5. Management of androgenetic alopecia.
Tosti A; Camacho-Martinez F; Dawber R
J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of androgenetic alopecia.
Crabtree JS; Kilbourne EJ; Peano BJ; Chippari S; Kenney T; McNally C; Wang W; Harris HA; Winneker RC; Nagpal S; Thompson CC
Endocrinology; 2010 May; 151(5):2373-80. PubMed ID: 20233794
[TBL] [Abstract][Full Text] [Related]
7. A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study.
Abdel-Raouf H; Aly UF; Medhat W; Ahmed SS; Abdel-Aziz RTA
Dermatol Ther; 2021 Jan; 34(1):e14678. PubMed ID: 33320406
[TBL] [Abstract][Full Text] [Related]
8. Androgenetic alopecia and current methods of treatment.
Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
[TBL] [Abstract][Full Text] [Related]
9. Androgenetic alopecia.
Piraccini BM; Alessandrini A
G Ital Dermatol Venereol; 2014 Feb; 149(1):15-24. PubMed ID: 24566563
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of minoxidil and tocopherol acetate ethosomes to reshape the hair Follicular Microenvironment and promote hair regeneration in androgenetic alopecia.
Yan A; Ruan R; Zhu X; Qiang W; Guan Y; Yu Q; Sun H; Liu M; Zhu H
Int J Pharm; 2023 Nov; 646():123498. PubMed ID: 37820942
[TBL] [Abstract][Full Text] [Related]
11. [Androgenetic alopecia in the man].
Bader U; Trüeb RM
Ther Umsch; 2002 May; 59(5):211-6. PubMed ID: 12090116
[TBL] [Abstract][Full Text] [Related]
12. Hair loss in women.
Camacho-Martínez FM
Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
[TBL] [Abstract][Full Text] [Related]
13. Male pattern baldness.
Hogan DJ; Chamberlain M
South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
[TBL] [Abstract][Full Text] [Related]
14. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
15. Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia.
Fu D; Huang J; Li K; Chen Y; He Y; Sun Y; Guo Y; Du L; Qu Q; Miao Y; Hu Z
Biomed Pharmacother; 2021 May; 137():111247. PubMed ID: 33517191
[TBL] [Abstract][Full Text] [Related]
16. Androgenetic alopecia treated with topical minoxidil.
De Villez RL
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):669-72. PubMed ID: 3549800
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
18. Comparative histological and immunohistochemical study on the effect of platelet rich plasma/minoxidil, alone or in combination, on hair growth in a rat model of androgenic alopecia.
Elsebay SAG; Nada HF; Sultan NSS; El-Waseef DAEA
Tissue Cell; 2022 Apr; 75():101726. PubMed ID: 35030343
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
20. [Androgenetic alopecia].
Jamin C
Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):801-3. PubMed ID: 12223962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
